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DNA microarray experiments require planning. Planning is driven by the 
experimental objectives. Good DNA microarray experiments have clear objectives. 
The objectives are not based on gene-specific mechanistic hypotheses like objectives 
of many other biological experiments, but it is erroneous to conceive of DNA 
microarray investigations as aimless data mining in search of unanticipated patterns 
that will provide answers to unasked questions.  
 
The objectives of many DNA microarray experiments can be characterized as either 
class comparison, class prediction, or class discovery (4). The objective of class 
comparison studies is to identify the genes that are differentially expressed in cells 
from different types of tissue, different kinds of patients, or in cells exposed to 
different experimental conditions. One example of class comparison is comparing 
gene expression in tumor tissue for patients who respond to a given treatment to gene 
expression in patients with the same cancer diagnosis who don’t respond to therapy 
(7). Another example of class comparison is comparing gene expression in kidney 
tissue of mice after 2 hours of ischemia to gene expression in kidney tissue of normal 
mice. The characteristic feature of class comparison studies is that the classes to be 
compared are defined independently of the expression data. The objective is to see 
how the expression profiles differ among the classes. 
 
Class prediction problems are similar to class comparison problems in that the classes 
are defined independently of the expression data. The emphasis in class prediction 
  2problems is in developing a multi-gene formula that can be applied to expression 
profiles of samples whose class is unknown, and to predict the class of the new 
samples. Using the example in the previous paragraph, class comparison involves 
identifying the genes that are differentially expressed between patients who respond 
to a specified treatment and those who don’t respond. Developing a formula that can 
be used to predict whether a new patient will respond to that therapy based on the 
gene expression profile of his or her tumor, is class prediction. Class prediction is 
particularly useful in medical problems of therapy selection or diagnostic 
classification or prognostic prediction. 
 
The third type of objective, class discovery, is quite different from class comparison 
or class prediction. In class discovery there is no classification defined independently 
of the expression profiles. The objective is to discover subsets (clusters) of the cases 
revealed by gene expression profiles and to identify the genes that distinguish the 
clusters. For example, Bittner et al. (1) examined expression profiles of patients with 
advanced malignant melanoma. The focus of the study was on attempting to identify 
a new taxonomy of advanced melanoma based on gene expression. No useful clinical 
classification existed. Class prediction also includes studies whose objective is to 
discover classes of genes that are co-regulated.    
 
 
Levels of replication 
 
  3A single dual-label DNA microarray assay provides a comparison of expression 
profiles for two RNA samples. The same is obtained for two Affymetrix GeneChip
TM 
assays. With only those two expression profiles, one cannot determine whether the 
expression profiles in the two RNA samples differ by more than experimental 
variability. This is because the magnitude of all of the relevant sources of variability 
cannot be estimated from the data consisting only of those two expression profiles. 
For example, the variability in expression profiles resulting from labeling the sample 
cannot be estimated.  
 
Investigators often ask, “how many replicates do I need.” If you had enough RNA in 
the two specimens to draw aliquots used to independently label and hybridize the 
RNA to many arrays, you could validly determine whether the expression profiles for 
those two RNA samples differed. Unfortunately, that is not usually the biologically 
relevant question. You will probably be thinking of comparing those two RNA 
samples because they were collected from different tissues or from cells under 
different conditions. The biologically relevant question is usually whether the two 
types of tissue differ with regard to expression profile, or to determine the effects on 
gene expression of changing the experimental conditions of the tissue culture. The 
two RNA samples may not be representative of the two tissue types. There may be 
substantial biological variability in gene expression among tissues of the same type 
and so comparing one RNA sample of one tissue type to one RNA sample of the 
other tissue type does not answer the biological question. The same applies to 
determining the effect of experimental manipulations on gene expression for cells 
  4grown in tissue culture. There will be variability in gene expression if the experiment 
is repeated because of variation in the administration of the experimental 
manipulations and differences in cell growth and harvesting.  
 
For class comparison and class prediction studies, multiple biological samples are 
needed, not replicate arrays of the same RNA samples. It is useful to have a few 
technical replicates of the same RNA sample to ensure that your procedures, reagents 
and equipment are working properly. Technical replicates should show good 
agreement. Technical replicates can also be protection against bad quality 
hybridizations. But technical replicates are not a substitute for biological replicates; 
that is, having enough samples of biologically independent specimens.  For tissue 
culture experiments, biologically independent specimens means specimens obtained 
from independent replications of the entire experiment. 
 
For studies attempting to discover new taxonomies of disease, it is useful to have 
expression profiles from cells in different parts of the biopsy specimen of the same 
patient, as well as having many independent patients represented. This helps you to 
evaluate whether the clusters you may obtain from subsequent analysis of the 
expression data represent a reproducible disease taxonomy.  
 
Pooling of Samples 
Some investigators pool samples in hope that by pooling they can reduce the number of 
microarrays needed. For example, in comparing two tissue types, a pool of one type of 
  5tissue could be compared to a pool of the other tissue type. Replicate arrays might be 
performed on each pooled sample. Although the pooled sample approach may be 
applicable for preliminary screening for differentially expressed genes, the approach does 
not provide a valid basis for statistical analysis. If only one array of each pooled sample 
is prepared, then there is no estimate of the variability associated with independently 
labeling and hybridizing the same pool onto different arrays. Even if the pools are 
hybridized to replicate arrays, you cannot evaluate how adequately a pool of that number 
of RNA specimens reflects the population of that tissue type. Unless multiple biologically 
independent pools of each type are arrayed, only the pooled samples themselves can be 
compared, not the populations from which they were derived. Selecting independent 
pools of samples is necessary in studying small model species where individuals must be 
combined in order to obtain enough RNA for assay (5).  
 
 
Pairing Samples for Co-hybridization on Two-Color Microarrays 
With Affymetrix GeneChips
TM , single samples are labeled and hybridized to individual 
arrays. Spotted cDNA arrays, however, generally use a dual-label system in which two 
RNA samples are separately reverse transcribed, labeled, mixed and hybridized together 
to each array. When using dual-label arrays one must decide on a design for pairing and 
labeling samples.  
 
The Reference Design 
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hybridized to each array. This is done so that the intensity of hybridization to a spot for a 
sample of interest is measured relative to the intensity of hybridization to the same spot 
on the same array for the reference sample. This relative hybridization intensity is 
standardized against variation in size and shape of corresponding spots on different 
arrays. Relative intensity is also standardized with regard to variation in sample 
distribution across each array since the two samples are mixed and therefore distributed 
similarly. The measure of relative hybridization generally used is the logarithm of the 
ratio of intensities of the two labels at the spot. 
 
The reference design is illustrated in Figure 1. Generally, the reference is labeled with the 
same dye on each array. Any gene-specific dye bias not removed by normalization affects 
all arrays similarly and does not bias class comparisons. Using a reference design, any 
subset of samples can be compared to any other subset of samples, hence the design is 
not dependent on the specification of a single mode of classification. The reference 
design is also convenient for class discovery using cluster analysis since the relative 
expression measurements are consistent with regard to the same reference. 
 
The Balanced Block Design 
A disadvantage of the reference design is that half of the hybridizations are used for the 
reference sample, which may be of no real interest.  Balanced block designs (2) are 
alternatives that can be used in simple situations. For example, suppose one wished to 
compare BRCA1 mutated breast tumors to BRCA1 non-mutated breast tumors, that equal 
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were of interest. One could hybridize on each array one BRCA1 mutated tumor sample 
with one non-mutated sample (Figure 2). On half of the arrays the BRCA1 mutated 
tumors should be labeled with the red dye and on the other half the non-mutated tumors 
should be labeled with the red dye. The analysis of data for the block design is based on 
an analysis of variance model for channel specific background adjusted intensities (3). 
The block design can accommodate n samples of each type using only n microarrays. No 
reference RNA is used at all. The reference design would require 2n arrays to 
accommodate n non-reference samples from each of the two classes. 
 
Although the balanced block design is very efficient in use of arrays, it has some serious 
limitations. For one, cluster analysis of the expression profiles cannot be performed 
effectively. Without a common reference, any comparisons between expression profiles 
of samples on different arrays will be subject to noise resulting from variation in size and 
shape of corresponding spots on different arrays and variation in sample distribution 
patterns on individual arrays (2). Also, since it is difficult or impossible to pair the 
samples simultaneously with regard to all of the class comparisons of interest, the block 
design is most effective when there is a single type of class comparison. The block design 
is also less effective than the reference design when there is large inter-sample variability 
and when the number of samples, rather than the number of arrays, is limiting (2). 
 
The Loop Design 
  8Loop designs (6) are another alternative to reference designs. When cluster analysis is 
planned, two aliquots of each sample must be arrayed for the loop design (Figure 3). The 
arrays link the samples together in a loop pattern. This design uses n arrays to study n 
samples, using two aliquots of each sample. The loop permits all pairs of samples to be 
contrasted in a manner that controls for variation in spot size and sample distribution 
patterns using a statistical model. Contrasting two samples far apart in the loop, however, 
involves modeling many indirect effects corresponding to the arrays linking the two 
samples of interest and this adds substantial variance to many of these contrasts (2). 
Consequently loop designs are very inferior to reference designs for cluster analysis. 
Loop designs can be used for class comparisons, but are less efficient than block designs. 
Loop designs are also less robust against the presence of bad quality arrays; two bad 
arrays can break the loop apart.   
 
Reverse Labeling 
Some investigators believe that all arrays should be performed both forward and reverse 
labeled. In general, this is unnecessary (3). 
 
The relative labeling intensity of the Cy3 and Cy5 may be different for different genes. 
Although the normalization process may remove average dye bias, gene-specific dye bias 
may remain. This is not important for comparing classes of non-reference samples using 
a reference design when the reference is consistently assigned the same label. Suppose, 
however, that for a group of patients we wanted to compare tumor tissue to matched 
normal tissue from the same individual using dual-label microarrays. One effective 
  9design would be to pair tumor and normal tissues from the same patient for co-
hybridization on the same array using the balanced block design (Figure 2). In half of 
these arrays the tumor should be labeled with Cy3 and in the other half of the arrays the 
tumor should be labeled with Cy5. It is not necessary to perform any reverse labeled 
replicate arrays of the tissues from the same patient (3). Gene-specific dye bias can be 
estimated in the balanced block design and used to adjust class comparisons without any 
reverse labeling arrays for the same two specimens. For a fixed total number of arrays, it 
is best to use the available arrays to assay tissue from new patients, using the balanced 
block design described, rather than to perform replicate reverse labeled arrays for single 
patients. The balanced block design is also best when there are n tumor tissues and n 
normal tissues even though the tissues are not from the same patients, or for comparing 
any two classes of samples. In these cases, the samples may be randomly paired, or 
paired based on balance with regard to potentially confounding variables such as the age 
of the specimens.  
 
In some cases a reference design is used in which the primary objective is comparison of 
classes of the non-reference samples but comparison to the internal reference is a 
secondary objective. For example, there may be several types of transgenic mouse breast 
tumors for comparison and the internal reference may be a pool of normal mouse breast 
epithelium. Because the primary interest is comparison among multiple tumor models or 
clustering the expression profiles of the tumors, a reference design may be chosen. Use of 
a pool of normal breast epithelium as the internal reference, rather than a mixture of cell 
lines, reflects some interest in comparison of expression profiles in tumor relative to 
  10normal breast epithelium. Comparison to a single pool of normal breast epithelium is 
somewhat problematic, however, for reasons described previously in the section on 
pooling. Nevertheless, the comparison may be of interest.  
 
In order ensure that the comparison of tumor expression to that of the reference is not 
distorted by gene-specific dye bias when using a reference design, some reverse labeled 
arrays are needed. One can then fit a statistical analysis of variance model to the 
logarithms of the intensities for each channel as described by Dobbin et al. (3). A 
separate analysis of variance model is fit for each gene and from the model one estimates 
the residual dye bias after normalization. These estimates are used by the model to 
automatically adjust the comparison of gene expression in tumor versus reference. Not all 
arrays need to be reverse labeled; 5-10 reverse labeled pairs of arrays will generally be 
adequate. Except for this purpose of comparison to the reference using a reference 
design, however, we recommend against reverse labeling of the same two RNA samples 
forward labeled on another array.  
 
Recommendations for dual-label designs 
When experimental objectives include discovery of new classes among the samples, then 
we recommend the reference design. If only comparison of pre-defined classes are 
planned but there are several kinds of comparisons to be made, then we again recommend 
the reference design. If only a single kind of class comparison is of interest and the 
expense of the microarrays is an important issue, then the balanced block design is 
recommended. If there is interest in measuring expression for each diseased specimen 
  11relative to a paired normal specimen from the same individual, then the balanced block 
design is again recommended. We do not recommend use of the loop design in most 
circumstances. 
 
If a common reference design is used, the reference RNA need not represent a 
biologically relevant contrast to the experimental samples. The main purpose of the 
reference RNA is to enable relative expression measures to be calculated in order to 
avoid technical measures of variation. Many investigators use reference RNA from a 
mixture of cell lines so that most genes will be expressed at a level that permits both 
increased and decreased expression in the experimental specimens to be measured. Using 
the same reference RNA for all experiments of a laboratory makes it possible to compare 
expression among different experiments, although other sources of variation may make 
this difficult.  
 
In cases where the common reference represents a pool of RNA from a source for which 
comparison is of interest, we recommend that the reference design (e.g. with the common 
reference consistently labeled with say Cy3) be supplemented by some arrays (e.g. 5-10) 
which represent dye swaps of the main set of arrays.  
 
  
 
 
Number of Biologically Independent Samples Needed 
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The number of independent biological samples needed depends on the objectives of the 
experiment. We will describe here a relatively straightforward method for planning 
sample size for testing whether a particular gene is differentially expressed between two 
pre-defined classes. Such a test can be applied to each gene if we adjust for the number of 
comparisons involved (8).  
 
This approach to sample size planning may be used for dual-channel arrays using 
reference designs or for single label oligonucleotide arrays. For dual-channel arrays the 
expression level for a gene is the log ratio of intensity relative to the reference sample; for 
Affymetrix GeneChip
TM arrays it is usually the log signal. The approach to sample size 
planning described here is based on the assumption that the gene-specific expression 
measurements are approximately normally distributed among samples of the same class. 
Let σ denote the standard deviation of the log expression level among samples within the 
same class and suppose that the means of the log expression in the two classes differ by δ 
for a particular gene. For example with base 2 logarithms, a value of δ=1 corresponds to a 
2-fold difference between classes. We assume that the two classes will be compared with 
regard to level of expression of each gene and that a statistically significant difference 
will be declared if the null hypothesis can be rejected at a significance level α. The 
significance level is the probability of concluding that the gene is differentially expressed 
between the two classes when in fact the means are the same (δ=0). The significance 
level α will be set stringently in order to limit the number of false positive findings since 
thousands of genes will be analyzed. The desired statistical power will be denoted 1-β.  
  13Statistical power is the probability of obtaining statistical significance in comparing gene 
expression among the two classes when the true difference in mean expression levels 
between the classes is δ. Statistical power is one minus the false negative rate (β).  
 
Under these conditions, the number of total samples required from different individuals 
or different replications of the experiment is approximately   
 
                        n = 4(zα/2 + zβ)
2 / (δ/σ)
2                       (1) 
where zα/2 and zβ denote the corresponding percentiles of the standard normal distribution 
(8). A standard normal distribution has mean zero and standard deviation one. The total 
area under the standard normal distribution (between the curve and the x-axis) is one. The 
area under the part of the curve to the left of the x-axis value of zα/2  is α/2. The area to 
the left of the x-axis value of zβ  is β. The n in formula (1) is the total number of 
experimental samples and also the number of arrays needed.  If the ratio of sample sizes 
in the two groups is k:1 instead of 1:1, then the total sample size increases by a factor of 
(k+1)
2/4k compared to formula (1).  
 
The fact that expression levels for many genes will be examined indicates that the size of 
α should be smaller than for experiments where the focus is on a single endpoint.  We 
recommend planning the sample size using α=0.001 and β=0.05. In our experience, most 
genes are not differentially expressed. Using α=0.001 results in 10 false discoveries per 
10,000 non-differentially expressed genes. This is less conservative than the multiple 
comparison adjustments commonly used for clinical trials, but seems reasonable for 
  14microarray studies where findings may be followed up in other kinds of assays. Using 
α=0.005, however, results in 50 false discoveries per 10,000 non-differentially expressed 
genes, which is too large a number of false leads even for most microarray studies.  For 
α=0.001 and β=0.05, the standard normal percentiles are zα/2  =-3.29 and  zβ  =-1.645. 
 
The parameter σ can usually be estimated based on data showing the degree of variation 
of expression values among similar biological tissue samples. For log-ratio expression 
levels in dual-label arrays using the reference design, we have seen the median value of σ 
of approximately 0.5 (using base 2 logarithms) for human tissue samples. The parameter 
δ represents the size of difference between the two classes we wish to be able to detect. 
For log2 ratios, δ=1 is often considered reasonable as it corresponds to a 2-fold difference 
in expression level between classes. Using α=0.001, β=0.05, δ=1 and σ=0.50 in the 
above formula gives a required sample size of approximately 25 total samples.  
 
The within class variability depends on the type of specimens; human tissue samples 
have greater variability than inbred strains of mice or cell lines. In experiments studying 
microarrays of kidney tissue for inbred strains of mice, the median standard deviation of 
log ratios for normal kidney was approximately 0.25, with little variation among genes. 
Using α=0.001, β=0.05, δ=1 and σ=0.25 in the above formula gives a required sample 
size of approximately 7 total samples. With such small sample sizes, formula (1) based 
on approximate normality would be more accurate if based on the t distribution, rather 
than the normal distribution. The constants in expression (1) corresponding to standard 
normal percentiles should be replaced by percentiles of the t distribution with mean zero, 
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determines n, the expression must be solved iteratively for n. In the case of  α=0.001, 
β=0.05, δ=1 and σ=0.25, we find that a total of 12 samples, 6 from each of the two 
classes being compared, are required for comparing the two classes. If this were a time 
series experiment with more than two time points, then one should plan for 6 animals per 
time point in order to enable expression profiles to be compared for all pairs of time 
points.  
 
When dual-label arrays are used with the balanced block design to compare either 
naturally paired or independent samples from two classes, a similar formulas applies:  
 
                        n = 2(zα/2 + zβ)
2 / (δ/τ)
2    (2) 
 
 n is the total number of independent experimental samples needed, as in expression (1) 
for the reference design, but only n/2 arrays are needed. For the balanced block design τ 
represents the standard deviation of variation across arrays in the log ratio of expression 
levels of samples, one from each class being compared (3). Preliminary data is generally 
needed to estimate τ in this case. In several cases that we have examined, τ
2 was 
approximately equal to 2 σ
2 and hence the total number of required non-reference 
samples was approximately the same for the reference design as for the balanced block 
design. The balanced block design required half as many arrays, however.  
 
  16Adequate methods for determining the number of samples required for gene expression 
studies whose objectives are class prediction or class discovery have not yet been 
developed. For such objectives the reference design is strongly recommended. The 
sample size formula (1) provides reasonable minimum sample sizes for class prediction 
studies. Often, however, developing multivariate class predictors or survival predictors 
involves extensive analyses beyond determining the genes that are informative 
individually. Also, a substantial portion of the cases may be set aside as a validation set 
for estimating the misclassification rate of the model developed on the test set of data. 
Consequently, larger sample sizes are generally needed for class prediction studies (7,9). 
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